Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver.
Bertocchi A, Carloni S, Ravenda PS, Bertalot G, Spadoni I, Lo Cascio A, Gandini S, Lizier M, Braga D, Asnicar F, Segata N, Klaver C, Brescia P, Rossi E, Anselmo A, Guglietta S, Maroli A, Spaggiari P, Tarazona N, Cervantes A, Marsoni S, Lazzari L, Jodice MG, Luise C, Erreni M, Pece S, Di Fiore PP, Viale G, Spinelli A, Pozzi C, Penna G, Rescigno M.
Cancer Cell. 2021 May 10;39(5):708-724.e11. doi: 10.1016/j.ccell.2021.03.004. Epub 2021 Apr 1.
TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis.
Tauriello DVF, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, Sevillano M, Ibiza S, Cañellas A, Hernando-Momblona X, Byrom D, Matarin JA, Calon A, Rivas EI, Nebreda AR, Riera A, Attolini CS, Batlle E.
Nature. 2018 Feb 22;554(7693):538-543. doi: 10.1038/nature25492. Epub 2018 Feb 14.
Management of malignant colon polyps: current status and controversies.
Aarons CB, Shanmugan S, Bleier JI.
World J Gastroenterol. 2014 Nov 21;20(43):16178-83. doi: 10.3748/wjg.v20.i43.16178.
Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/beta-Catenin Signaling Pathway and EMT.
Wang J, Cai H, Liu Q, Xia Y, Xing L, Zuo Q, Zhang Y, Chen C, Xu K, Yin P, Chen T.
Am J Chin Med. 2020;48(3):703-718. doi: 10.1142/S0192415X20500354. Epub 2020 Apr 24.
Astragali Radix-Curcumae Rhizoma normalizes tumor blood vessels by HIF-1alpha to anti-tumor metastasis in colon cancer.
Liang Y, Su T, Zhu S, Sun R, Qin J, Yue Z, Wang X, Liang Z, Tan X, Bian Y, Zhao F, Tang D, Yin G.
Phytomedicine. 2025 May;140:156562. doi: 10.1016/j.phymed.2025.156562. Epub 2025 Feb 24.
Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.
Allen WL, Johnston PG.
Pharmacogenomics. 2005 Sep;6(6):603-14. doi: 10.2217/14622416.6.6.603.
Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones.
Cayrefourcq L, Thomas F, Mazard T, Assenat E, Assou S, Alix-Panabières C.
Mol Cancer. 2021 Feb 8;20(1):30. doi: 10.1186/s12943-021-01326-6.
Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer.
Sun TT, Wang Y, Cheng H, Xiao HZ, Xiang JJ, Zhang JT, Yu SB, Martin TA, Ye L, Tsang LL, Jiang WG, Xiaohua J, Chan HC.
Biochim Biophys Acta. 2014 Mar;1843(3):618-28. doi: 10.1016/j.bbamcr.2013.12.013.
Early stage colon cancer.
Freeman HJ.
World J Gastroenterol. 2013 Dec 14;19(46):8468-73. doi: 10.3748/wjg.v19.i46.8468.
Growth rates of benign and malignant neoplasms of the colon.
Spratt JS, Spratt JA.
Prog Clin Biol Res. 1985;186:103-20.
